EUVIMEDEUVIMED entdecken
Crossref

Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain

Carles Rubio Maturana, Marta Guerrero, Maria Casas Claramunt, Susana Nuria Ayala-Cortés, Victoria López, Patricia Martínez-Vallejo, Begoña Treviño, Elena Sulleiro, Juliana Esperalba, Ariadna Rando, Diana Pou, Maria Luisa Aznar und 5 weitere

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2025

DOI: 10.1016/j.eimce.2024.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2025. Verfasst von Carles Rubio Maturana und 16 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Univesitat Autònoma de Barcelona, Spain. Electronic add…. Hauptthemen laut MEDLINE: Transients and Migrants, Vaccine-Preventable Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Almost 281 million people were living in a foreign country in 2022, and more than 100 million were displaced because of war conflicts and human right violations. Vaccination coverage of infectious diseases in migrants from some disadvantaged settings could be lower than reception countries populations, consequently seroprevalence studies and better access to vaccination could contribute to reducing these differences. METHODS: A descriptive retrospective cross-sectional study was conducted including migrants, living ≤5 years in the reception country and ≥16 years old, who requested a medical exam between January 1st, 2020 and January 31st, 2021. Seroprevalence assessment was performed, and vaccination was offered to those individuals without immunity to hepatitis B, hepatitis A, varicella, measles, mumps, and rubella. RESULTS: A total of 315 migrants were attended during the study period. Immunity protection at arrival was 252/296 (85.1%) for measles, 274/295 (92.9%) for rubella, 257/296 (86.8%) for mumps, 264/295 (89.5%) for varicella, 267/313 (85.3%) for hepatitis A, and 104/300 (34.6%) for hepatitis B. The final immunity protection after full vaccination schedules was 278/296 (93.9%) for measles, 287/295 (97.3%) for rubella, 274/296 (92.6%) for mumps, 276/295 (93.6%) for varicella, 280/313 (89.5%) for hepatitis A, and 139/300 (46.3%) for hepatitis B. CONCLUSIONS: The vaccination intervention has increased immunity rates for the studied diseases in the attended migrants in our center, however, such interventions should be maintained to reach local population immunization levels. Moreover, the collaboration between shelter and reference specialized health centers is fundamental to implement such vaccination programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transients and MigrantsVaccine-Preventable DiseasesHumansSeroepidemiologic StudiesSpainCross-Sectional StudiesRetrospective StudiesMaleFemaleAdultAdolescentYoung AdultChildChild, PreschoolMiddle AgedVaccinationInfantVaccination Coverage

Stichwörter der Autor:innen

Asylum seekersEnfermedades infecciosasInfectious diseasesMigraciónMigrationPrevenciónPreventionRefugeesRefugiadosSolicitantes de asiloVaccinesVacunas

Autor:innen und Institutionen

  • Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Univesitat Autònoma de Barcelona, Spain. Electronic address: carles.rubio@vhir.org.
  • EAP Universitat, ICS Barcelona, Spain.
  • EAP d'Alcarràs, ICS Lleida, Spain; Centre Vacunacions Internacional Lleida, ICS Lleida, Spain.
  • International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
  • Microbiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Univesitat Autònoma de Barcelona, Spain.
  • International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecci…

Zitieren

APA

Rubio Maturana, C., Guerrero, M., Casas Claramunt, M., Ayala-Cortés, S. N., López, V., Martínez-Vallejo, P., Treviño, B., Sulleiro, E., Esperalba, J., Rando, A., Pou, D., Aznar, M. L., Bosch-Nicolau, P., Salvador, F., Oliveira-Souto, I., Molina, I., & Serre-Delcor, N. (2025). Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain. Enfermedades infecciosas y microbiologia clinica (English ed.). https://doi.org/10.1016/j.eimce.2024.04.010

Vancouver

Rubio Maturana C, Guerrero M, Casas Claramunt M, Ayala-Cortés SN, López V, Martínez-Vallejo P, et al. Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain. Enfermedades infecciosas y microbiologia clinica (English ed.). 2025. doi:10.1016/j.eimce.2024.04.010

BibTeX
@article{RubioMaturana2025,
  author = {Rubio Maturana, Carles and Guerrero, Marta and Casas Claramunt, Maria and Ayala-Cortés, Susana Nuria and López, Victoria and Martínez-Vallejo, Patricia and Treviño, Begoña and Sulleiro, Elena and Esperalba, Juliana and Rando, Ariadna and Pou, Diana and Aznar, Maria Luisa and Bosch-Nicolau, Pau and Salvador, Fernando and Oliveira-Souto, Inés and Molina, Israel and Serre-Delcor, Núria},
  title = {Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2025},
  doi = {10.1016/j.eimce.2024.04.010}
}
Kostenlos starten →